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Abstract. – OBJECTIVE: Prevalence of asthma
and vitamin D deficiency has been increasing and
leading to significant morbidities. This study aimed
to compare the vitamin D levels in the pre-school
children with asthma and in healthy controls and to
assess the relationship between vitamin D levels
and asthma clinical parameters and control.
PATIENTS AND METHODS: Vitamin D
[25(OH)D3] levels were measured in 102 pre-
school children, aged 1-4 years with asthma and
102 healthy controls in winter. The patients with
asthma were grouped according to serum vitamin
D levels as sufficient, insufficient and deficient.
Asthma control was classified according to the
Global Initiative for Asthma (GINA) guidelines and
the Test for Respiratory and Asthma Control in
Kids (TRACK) in 1-4 years-old children.
RESULTS: Serum vitamin D levels were 22.64
(9.96) ng/ml in the asthma group and 32.11 (14.74)
ng/ml in the control group (p = 0.001). Total num-
ber of exacerbations during the previous year
were significantly lower in the vitamin D sufficient
group, compared to the deficient and insufficient
groups (p = 0.03). Frequency of patients with con-
trolled asthma was higher in the sufficient group
compared to the deficient and insufficient groups
(p = 0.001 and p = 0.001, respectively). There was
a positive correlation between serum vitamin D
levels and asthma control. 
CONCLUSIONS: The frequency of vitamin D de-
ficiency and insufficiency was higher in children
with asthma, compared to the controls. There-
fore, we suggest that lower levels of vitamin D are
associated with poor asthma control and in-
creased asthma severity.
Key Words:
Asthma, Vitamin D, Pre-school children, Asthma con-
trol, Test for respiratory and asthma control in kid.
Introduction
Asthma is among the common chronic in-
flammatory diseases in childhood and the first
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symptoms are observed in childhood in half of
the cases1. Incidence and cost of asthma in both
developed and developing countries have been
increasing. Asthma is one of the most signifi-
cant morbidities of childhood due to the school
absenteeism, emergency room visits and hospi-
talization1,2. Currently, the prevalence of vita-
min D deficiency has been increasing parallel
with asthma3. Natural vitamin D production (ap-
proximately 80%) is identified by the ultraviolet
(UV) component of sunlight through cutaneous
synthesis4-6. The adoption of a Western-type
lifestyle, altered eating habits, and spending less
time doing outdoor activities are thought to play
a role in the increased prevalence of vitamin D
deficiency7-8. Vitamin D has been suggested to
contribute to asthma pathogenesis by improving
immune function, exhibiting anti-inflammatory
effects, reducing the steroid resistance, increas-
ing the effects of glucocorticoids, slowing the
cell cycle down, and reducing remodeling3,4,9,10.
Many studies have reported a possible rela-
tionship between asthma and vitamin D deficien-
cy; however, evidence is still controversial.
Some cross-sectional studies7,11-14 have shown
that serum vitamin D levels in asthmatic children
are lower than in healthy children. Other studies
have not observed such a significant relation-
ship15-19, whereas a limited number of studies
have shown that increased serum vitamin D lev-
els may increase the risk of asthma20,21. In addi-
tion, vitamin D levels and asthma severity, exac-
erbation, emergency room visits, and duration of
hospitalization may vary according to the studies
in asthma patients4,11,19,22,23. 
There are a limited number of studies which
investigated the relationship between asthma
control and vitamin D levels. The data obtained
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from these studies mostly include school-age
children, adolescent and adult origin. In addition,
there are no studies examining the relationship
between vitamin D and asthma control in
preschool children.
The present study aimed to compare vitamin
D levels in pre-school children with asthma and
in healthy controls and to assess the relationship
between vitamin D levels and asthma clinical
parameters, as well as the effects on asthma
control.
Patients and Methods
Study Population
One hundred two children with mild-to-
moderate asthma according to the Global Initiative
for Asthma (GINA) who were admitted to the Pe-
diatric Immunology and Allergy outpatient clinic
at Eskisehir State Hospital Between December
2014 and February 2015 were enrolled. The con-
trol group consisted of 102 healthy children ad-
mitted to the general pediatric outpatient clinic
aged 1-4 years. The diagnosis of asthma was made
by clinical characteristics of cough and wheezing
during exercise, laughing, or crying in the absence
of a respiratory infection varies over time and
which is reversible with bronchodilator adminis-
tration, at least 3 documented episodes of wheez-
ing as suggested by GINA guidelines1. Patients
and control group who had a history of consump-
tion of any supplements of vitamin D or drugs that
modulate serum vitamin D levels, such as sys-
temic corticosteroids, anticonvulsants, and those
who had acute chronic diseases were excluded. In
addition, the presence of allergies was also an ex-
clusion criterion.
Study Design and 
Ethics Committee Approval 
This case-control study was approved by the
Ethics Committee of Eskisehir State Hospital.
The study was performed in accordance with the
principles of the Helsinki Declaration. Written
informed consent was obtained from each child
and his/her parents.
Data Collection
Age, gender, height, weight, parental allergic
diseases (asthma, allergic rhinoconjunctivitis and
atopic dermatitis), and sunlight exposure (at least
10 minutes between 10 and 15 hours) were
recorded24.
The Asthma Symptom Score (ASS) consisted
of respiration rate, retractions, dyspnea and
wheezing, each of which was rated 0-3; 0 being
the least, 3 being the most severe25. Emergency
Department visits, number of in-hospital stays,
number of exacerbations within the last year
were recorded.
According to the GINA assessment of asthma
severity, the pediatric allergy specialist assessed
asthma severity in consideration of daytime and
nighttime symptoms, the number of exacerba-
tions, and values as mild and moderate asthma1.
According to the GINA assessment of asthma
control in children 5 years and younger, the pa-
tients assessed asthma control in consideration
daytime and nighttime symptoms, any activity
limitation due to asthma and reliever medication
needed more than once a week (in the past 4
weeks) values as “well controlled, partly con-
trolled and uncontrolled”1. 
The TRACK questionnaire suggested in
measurement of asthma control in children un-
der 4 years old by GINA was completed by
parents or caregivers. The TRACK question-
naire completed by the parents or caregivers is
a test that consists of five items that measure
asthma control. Each item reflects the clinical
points lowest as “0” and as highest “20” in-
cluding 5 questions26.
The questionnaire consists of the frequency
of respiratory problems per week such as
wheezing, coughing, or shortness of breath oc-
curring during the past four weeks, the frequen-
cy of sleep disturbances at night per week, the
frequency of interference with playing the
games, going to school, or participating in nor-
mal activities for her/his age, the frequency of
given rescue treatment within the past three
months (relaxing medication) and during the
last 12 months, and the frequency of using sys-
temic corticosteroids due to respiratory prob-
lems uncontrollable by other drugs. The sum of
these items provided the total score, ranging
from 0 to 100. The higher scores indicated bet-
ter disease control (controlled > 80), whereas a
score of less than 80 (uncontrolled < 80) sug-
gested potential respiratory problems. The relia-
bility and validity of TRACK was demonstrated
by Yilmaz et al27.
Peripheral venous blood samples were ob-
tained to measure serum Vitamin D, parathor-
mon (PTH), calcium (Ca), phosphorus (P), alka-
line phosphatase (ALP), immunoglobulin E
(IgE) levels, and peripheral blood eosinophil
27
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Asthma group (n = 102) Control group (n = 102) p*
Age 3.0 (2.5-4.0) 3.0 (2.0-4.0) 0.49
Gender (male) 57 (55.9) 52 (51.0) 0.48$
Height (cm) 95.0 (88.0-100.0) 96.0 (88.0-101.3) 0.57
Weight (kg) 14.0 (12.4-15.0) 14.0 (13.0-16.0) 0.11
Parental atopy presence 56 (54.9) 41 (40.2) 0.04$
Sunlight exposure (10 minute >) 16 (15.7) 24 (19.6) 0.16$
Vitamin D levels (ng/ml) 22.64 (9.96) 32.11 (14.74) 0.001†
Vitamin D status 0.001$
Deficient (< 20 ng/mL) 47 (46.1) 25 (24.5)
Insufficient (20-30 ng/mL) 31 (30.4) 24 (23.5)
Sufficient (> 30 ng/mL) 24 (23.5) 53 (52)
Parat Hormone (ng/ml) 37.05 (25.82-45.68) 31.15 (22.88-39.75) 0.02
Ca 9.9 (0.4) 10.3 (0.5) 0.001†
P 4.9 (0.6) 5.5 (0.7) 0.001†
ALP 210.0 (182.3-256.3) 189.5 (164.5-237.3) 0.02
Eo 192.0 (93.5-328.5) 180.0 (88.7-300.0) 0.78
IgE 34.1 (16.5-107.2) 15.5 (6.8-39.3) 0.001
Table I. Sociodemographic characteristics and laboratory findings of the children in the study.
*Mann-Whitney U-test (expressed in median-interquartile range); †Student t-test. $Pearson’s Chi-Square (n-%).
was counted on the same day. Ca, P and ALP
were measured by spectrophotometrically in the
biochemistry laboratory (AU 5800 Clinical
Chemistry Analyzer, Beckman Coulter Inc.,
USA).
Vitamin D and PTH Measurement
25 (OH) D3 was measured by ECLIA (electro-
chemiluminescence immunoassay; Cobas E601 Im-
munoassay System, Roche Diagnostics, Indianapo-
lis, IN, USA), parathormon (PTH) CLIA (chemilu-
minescence immunoassay; Architect I2000SR Im-
munoassay System, Abbott Diagnostics, Lake For-
est, IL, USA) in the hormon laboratory.
The values for vitamin D levels > 30 ng/ml
were considered as sufficient, those between 20
and 30 ng/ml as insufficient, and lower than 20
ng/ml as deficient28.
Total Eosinophil Counts 
Eosinophil counts were recorded from a com-
plete blood count device (Cell Dyne 3700 Ana-
lyzer, Abbott Diagnostics, Lake Forest, IL,
USA). 
Total IgE Measurement 
Two milliliters of venous blood samples were
collected into standard biochemical tubes.
These samples were studied by chemilumines-
cence immunometric method (IMMULITE
2000 Immunoassay System, Siemens Health-
care, Malvern, PA, USA) in the biochemistry
laboratory.
Statistical Analysis
The statistical analysis was performed using
the SPSS 15.0 software program (SPSS Inc.,
Chicago, IL, USA). The Kolmogorov-Smirnov
test was used to analyze the normally distributed
data. The Student’s t-test and ANOVA were used
to compare normally distributed data between in-
dependent groups. Quantitative data are ex-
pressed as mean ± standard deviation. The
Mann-Whitney U-test and Kruskal-Wallis test
were used for independent groups with abnormal
distribution. Quantitative data are expressed as
median (interquartile range). Pearson’s chi-
square (linear by linear correlation) was used to
compare non-parametric variables (with a preset
probability of p < 0.05). The correlation of vita-
min D levels and clinical variables were ana-
lyzed by the Spearman’s correlation analysis
(with a preset probability of p < 0.05). A p value
< 0.05 was considered statistically significant.
Results
Sociodemographic Characteristics of
Asthmatic Children and Healthy Controls
The median (interquartile range) ages of the
asthmatic and healthy control children were 3.0
(2.5-4.0) years and 3.0 (2.0-4.0) years, respec-
tively (p = 0.49). Total of 55.9% of the patients
and 51.0% of the control subjects were males
(Table I). Age, height, weight, and sunlight ex-
posure were similar between the patients and
29
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control groups. Parental atopy was 56 (54.9%) in
the asthma group and 41 (40.2%) in the control
group (p = 0.04) (Table I).
Laboratory Findings of Asthmatic 
Children and Healthy Controls
Vitamin D levels were 22.64 (9.96) ng/ml in
the patient group and 32.11 (14.74) ng/ml in the
control group, indicating statistical significance
(p = 0.001) (Figure 1) (Table I). When the asth-
ma patients were divided into groups according
to the levels of vitamin D, rates of deficiency
was 47 (46.1%), insufficiency was 31 (30.4%),
sufficienc 24 (23.5%) in the asthma group while
deficiency 25 (24.5%), insufficiency 24 (23.5%),
sufficiency 53 (52%) in the control group. Vita-
min D status different between the groups (p =
0.001) (Table I). 
Serum PTH, Ca, P, and ALP levels were sig-
nificant different between the asthma and control
groups (p = 0.02; p = 0.001; p = 0.001 and p =
0.02 respectively) (Table I).
None of the children in the patient and control
groups had active rickets.
Serum IgE and Eosinophil Counts
The asthma patients exhibited significantly
higher IgE levels compared to the control group
median (interquartile range) 34.1 (16.5-107.2)
IU/ml and 15.5 (6.8-39.3) IU/ml, respectively; p
= 0.001)) (Table I). The eosinophil counts did
not differ significantly between the asthma and
control groups (p = 0.78) (Table I).
Sociodemographic Characteristics of 
Children with Asthma According to 
Vitamin D Levels
The median (interquartile range) ages of the
deficient, insufficient, and sufficient groups were
3.5 (2.5-4.0) years, 3.0 (2.0-4.0) years, and 2.0
(3.3-4.0) years, respectively (p = 0.35). Males
represented 55.3% of the deficient group, 58.1%
of the insufficient group, and 54.2% of the suffi-
cient group (p = 0.95) (Table II).
The presence of height, weight, and parental
atopy did not significantly differ between the
Figure 1. The box plot of serum vitamin D levels in chil-
dren with asthma and control groups.
Deficient Insuficient Sufficient
(< 20 ng/ml) (20-30 g/ml) (> 30 ng/ml)
(n = 47) (n = 31) (n = 24) p*
Age 3.5 (2.5-4.0) 3.0 (2.0-4.0) 2.0 (3.3-4.0) 0.35
Gender (male) 26 (55.3) 18 (58.1) 13 (54.2) 0.95$
Height (cm) 14.5 (13.5-15.5) 14.0 (11.5-15.0) 13.8 (11.0-14.4) 0.35
Weight (kg) 95.6 (8.2) 92.0 (9.1) 91.5 (9.6) 0.13†
Parental atopy presence 27 (57.4) 16 (51.6) 13 (54.2) 0.88$
Sunlight exposure (10 minute >) 3 (6.4) 4 (12.9) 9 (37.5) 0.003$
Vitamin D levels (ng/ml) 14.03 (2.79) 24.65 (3.22) 36.91 (6.10) 0.001†
Parathormone (ng/ml) 42.6 (35.2-49.0) 34.4 (25.0-45.3) 27.1 (20.3-38.2) 0.002
Ca 9.9 (0.4) 9.9 (0.5) 10.0 (0.5) 0.5†
P 5.0 (0.7) 5.0 (0.6) 5.0 (0.6) 0.47†
ALP 212.0 (186-255) 213 (177-257) 202.5 (166-259.5) 0.79
Eo 185 (101-321) 198 (95-403) 201.5 (51-273.5) 0.8
IgE 46.4 (17-124) 26.8 (16.5-97.4) 28.9 (16.5-97.1) 0.48
Table II. Relationship between serum levels of vitamin D and sociodemografic and laboratory findings of the patient group.
$Pearson’s Chi-Square [% (n)]; *Kruskal Wallis Test-Chi Square; †ANOVA.
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groups (p > 0.05 for all) (Table II). The patient
ratio receiving adequate sunlight exposure was
6.4%, 12.9 and 37.5% in the deficient, insuffi-
cient, and sufficient groups, respectively, sug-
gesting a statistical significance (p = 0.003)
(Table II). 
Laboratory Fnding According to the
Vitamin D Status of Children with Asthma
Vitamin D levels in children with asthma were
14.03 (2.79) ng/ml in deficient group, 24.65
(3.22) ng/ml in the insufficient group and 36.91
(6.10) ng/ml in the sufficient group (p = 0.001),
while parathormon levels were 42.6 (35.2-49.0)
ng/ml) in the deficient group, 34.4 (25.0-45.3)
ng/ml in the insufficient group, and 27.1 (20.3-
38.2) ng/ml in the sufficient group (p = 0.002)
(Table II). Serum Ca, P and ALP levels did not
differ significantly between deficient, insuffi-
cient and sufficient groups (p > 0.05 for all)
(Table II). 
Serum IgE levels and eosinophil counts did
not differ significantly between the deficient, in-
sufficient, and sufficient groups (p = 0.48 and p
= 0.8, respectively) (Table II). 
Clinical Characteristics According to the
Vitamin D Status in Children with Asthma
The median (interquartile range) age of initial
asthma diagnosis in the asthma groups were not
significant (p = 0.07). The median (interquartile
range) Asthma Symptoms Scores did not differ
significantly between the asthma groups (p =
0.28) (Table III).
The median (interquartile range) number of
asthma exacerbations within the last year was
higher in the deficient and insufficient group,
compared to the sufficient group 3 (2-4), 3 (1-4)
and 2 (1-2,8), respectively (p = 0.03) (Table III).
No statistically significant difference was ob-
served in terms of the number of emergency ser-
vice visits and the number of hospitalizations
within the last year among the groups (p = 0.15
and p = 0.51, respectively) (Table III). 
Asthma severity showed a statistically signifi-
cant difference among the vitamin D groups.
Mild asthma rate was 36.2%, 41.9% and 75% in
deficient, insufficient and sufficient groups, re-
spectively whereas moderate asthma rate was
63.8%, 58.1% and 25% in deficient, insufficient
and sufficient groups (p = 0.0 06) (Table III). 
The mean TRACK score was 52.2 (19.8), 55.5
(19.8), and 70.2 (16.9) in the deficient, insuffi-
cient, and sufficient groups, respectively (p =
0.001) (Figure 2) (Table III). According to the
TRACK scoring, 10.6% asthma was controlled
in the deficient group, 16.1% in the insufficient
group, and 45.8% in the sufficient group. Uncon-
trolled asthma (TRACK scores < 80) was 89.4%,
83.9%, and 54.2% in the deficient, insufficient,
and sufficient groups; therefore the difference
among the groups was significant (p = 0.001)
Deficient Insuficient Sufficient
(< 20 ng/ml) (20-30 g/ml) (>30 ng/ml)
(n = 47) (n = 31) (n = 24) p*
Duration of disease (months) 18 (6-24) 10 (4-18) 13.5 (9.8-18) 0.07
Asthma Symptoms Scores 2 (1-3) 2 (1-3) 1 (1-3) 0.28
Asthma morbidity (last year)
Number of exacerbation 3 (2-4) 3 (1-4) 2 (1-2.8) 0.03
Number of emergency service visits 3 (2-4) 2 (3-5) 2 (2.5-3) 0.15
Number of hospitalizasyon 0 (0-1) 0 (0-1) 0 (0-1) 0.51
Asthma severity 0.006$
Mild 17 (36.2) 13 (41.9) 18 (75.0)
Moderate 30 (63.8) 18 (58.1) 6 (25.0)
Asthma Control (GINA) 0.001$
Well control 4 (8.5) 3 (9.7) 17 (70.8)
Partial control 18 (38.3) 16 (51.6) 3 (12.5)
Uncontroll 25 (53.2) 12 (38.7) 4 8 (16.7)
TRACK Scores 52.2 (19.8) 55.5 (19.8) 70.2 (16.9) 0.001†
Control 5 (10.6) 5 (16.1) 11 (45.8) 0.001$
Uncontrol 42 (89.4) 26 (83.9) 13 (54.2)
Table III. Relationship between serum levels of vitamin D and sociodemografic and laboratory findings of the patient group.
$Pearson’s Chi-Square [% (n)]; *Kruskal Wallis Test-Chi Square; †ANOVA.
Similarly, duration of disease, number of
emergency service visits, and the number of hos-
pitalization within the last year and ASS was not
correlated with serum vitamin D level (r = -0.07,
r = -0.14, r = -0.11, r = -0.15, r = 0,17 and r = -
0.11 respectively, p > 0.05 for all) (Table IV).
Discussion
In the present study, vitamin D levels in
preschool children with asthma were lower than
the healthy controls. When asthma patients were
classified as deficient (< 20 ng/ml), insufficient
(20-30 g/ml), and sufficient (> 30 ng/ml) accord-
ing to their vitamin D levels, asthma control rates
according to GINA and TRACK were statistical-
ly higher in the sufficient group, compared to the
deficient and insufficient group. In addition,
there was a positive correlation between level of
asthma control and vitamin D levels. The number
of exacerbations within the last year was lower in
the sufficient group compared to the other
groups. The percentage of sunlight exposure was
significantly lower in deficient and insufficient
groups than the sufficient group.
The development of asthma is associated with
the large number of immunological markers.
Asthma prevalence and vitamin D deficiency
rates have been increasing worldwide. An in-
creasing body of evidence supports the pleotrop-
ic effects of vitamin D on various chronic disor-
ders including those associated with immune reg-
ulatory function. This is associated with a num-
ber of childhood diseases such as type 1 diabetes
mellitus, celiac disease, and asthma3. The reduc-
tion in vitamin D production on the skin through
short-term exposure to sunlight, and inadequate
access to food and supplements lead to vitamin D
deficiency in children in particular. This supports
the idea that there is a decrease in the time spent
in open areas due to the Western lifestyle. For in-
stance, people in the United States have been es-
timated to spend approximately 93% of their
time indoors7,8.
The serum levels of 25(OH) D3 are measured
as a marker of vitamin D status due to its long
half-life (~15 days). There are still no studies
showing the effects of vitamin D in initiating
asthma. The results of high 25 (OH) D3 levels re-
lated to reducing the incidence of asthma is con-
troversial. The birth cohort study in Australia
concluded that low 25 (OH) D3 levels at the age
of 6 have been shown to be predictive of later de-
31
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(Table III). When patients were classified ac-
cording to TRACK score those with controlled
asthma had higher vitamin D levels compared to
patients with uncontrolled asthma group (30.04
ng/ml vs. 20.95 ng/ml, p = 0.001) 
According to GINA, well asthma control was
70.8% in the sufficient group, 8.5% in the defi-
cient group, and 9.7% in the insufficient group
and the difference between the groups was statis-
tically significant (p = 0.001) (Table III). Vita-
min D levels were 32.09 ng/ml, 20.19 ng/ml, and
19.32 ng/ml in well, partially and uncontrolled
asthma groups, respectively. There were statisti-
cally significant differences between the groups
(p = 0.001) (Figure 3).
Correlation Between Serum Vitamin D
Levels and Clinical Variables
Vitamin D levels were correlated with the du-
ration of sunlight exposure (r = 0.25; p = 0.01),
number of exacerbations in the last year (r = -
0.27, p = 0.006). Asthma severity, asthma con-
trol, and TRACK score were correlated with
serum vitamin D level (r = -0.34, r = 0.46 and r
= 0.29 respectively, and p = 0.001, p = 0.001,
and p = 0.004, respectively) (Figure 3) (Table
IV).
Age, gender, parental atopy presence, IgE lev-
els and eosinophil count were not correlated with
serum vitamin D level (r = -0.80, r = 0.05, r =
0.02, r = -0.15 and r = -0.07 respectively, p>
0.05 for all).
Figure 2. The box plot of TRACK Scores in children
grouped according to the Vitamin D levels.
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veloping atopy or asthma phenotypes in 14-
years-old boys29. Similarly, Van Oeffelen et al20
showed that elevated vitamin D levels at the age
of 4 decrease the asthma risk at the age of 8. On
the contrary, Tolpannen et al21 claimed that high
25 (OH) D3 levels at the age of 10 increased the
asthma incidence and wheezing risk in subse-
quent years.
Vitamin D levels have been shown to be sta-
tistically significantly lower in asthmatic chil-
dren compared to the healthy children in studies
of Mediterranean countries such as Italy, Cyprus,
and Turkey, as well as Middle Eastern countries
such as Iran and Qatar7,15,25,30,31. As a result of the
current study, vitamin D levels in asthmatic chil-
dren were determined to be lower compared to
the control group, similar to other studies. The
reason for the low levels of vitamin D in asth-
matic children compared to the control group is
spending more time in indoor areas due to exac-
Figure 3. The relationship existing between vitamin D serum levels and asthma control A, Scatter plot shows the relation-
ship existing between vitamin D serum levels and TRACK scores. B, Distribution of vitamin D serum levels in children
grouped according to the “GINA assessment of asthma control in children 5 years and younger”. Horizontal lines show
mean values.
Evidence suggests that there are multiple bio-
logical effects of vitamin D in the pathogenesis
of respiratory diseases such as asthma and aller-
gic diseases, as well as bone metabolism34. Vita-
min D deficiency can affect the lung develop-
ment and functions35. In vivo and in vitro animal
model studies demonstrate that vitamin D has an
important role in modulation of normal lung de-
velopment; thus, vitamin D deficiency may im-
pair lung development36. Furthermore, vitamin D
has been shown to have various effects in the in-
nate and adaptive immune systems. Airway ep-
ithelium, which is an element of the innate im-
mune system against the external area, contains a
high level of enzyme converting 25(OH)D3 to an
active form of 25(OH)D3. This active form of vi-
tamin D has a local effect on infection responses.
Therefore, it is effective in reducing inflamma-
tion due to infections9. Vitamin D affects the im-
mune system by increasing the expression of
cathelicidin, which is an important antimicrobial
peptide against respiratory pathogens10,14. Obser-
vational studies8,37,38 suggest that vitamin D defi-
ciency in children and adults can contribute to
the incidence of wheezing and increases the risk
of respiratory infections that cause asthma exac-
erbations. In a randomized placebo controlled
study conducted by Urashima et al39, influenza A
infection was seen in Japanese school-age chil-
dren taking 1200 IU of vitamin D 3 per day. In-
terestingly, less exacerbation was observed in
subgroup of asthmatic children receiving vitamin
D supplements compared to the control group.
Vitamin D also effects the adaptive immune sys-
tem through Th1, Th2, and regulatory T cells (T
reg)9. Vitamin D promotes induction of T reg
cells providing the controlling of inhibitor cy-
tokine secretion (IL-10 and TGF-β) and CD4+ T
lymphocytes (Th1, Th2). Vitamin D was shown to
inhibit the Th17 cytokine production related to
asthma severity and low steroid response. Vita-
min D can also increase glucocorticoid respon-
siveness in steroid resistant asthma3,5,10. Vitamin
D deficiency decreases corticosteroid responsive-
ness, contributing to asthma attacks4. By these
mechanisms, vitamin D may also have a thera-
peutic role in reducing asthma attacks4.
In the general population, despite controversial
evidence on the association of vitamin D with
asthma thus far, there is an inverse relationship be-
tween sufficient levels of vitamin D and asthma
medication use, and asthma severity indicators
such as exacerbation and hospitalization in chil-
dren with asthma4,11,19,22,23. In the present study,
33
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erbation and protecting the infections triggering
this and as a result they were exposed to less sun-
light. However, Dogru et al19 showed that there
was no significant difference between asthmatic
children and healthy subjects in Turkey. This dif-
ference may arise from the difference in weather
during which the two studies were performed.
Moreover, it may be also caused by the lower
age compared to other groups of patients consti-
tuting our study group.
In a cross-sectional study32 conducted on chil-
dren at the age of 5-11 in Italy, vitamin D defi-
ciency was determined in 53.5% of the children
with asthma and insufficiency in 37.3%, while
vitamin D sufficiency was detected in 9.4% of
children. Deficient, insufficient, and sufficient
rates were 43.3%, 47.5%, and 9.2% respectively
in a study conducted with children at the ages of
3-8.5 in our country. In another study conducted
with children at the ages of 2-14, the rates were
67%, 20%, and 9.5%. The deficiency rate was
46.1% in our study, which was similar to other
studies25, while insufficiency and sufficient was
30.4% and 23.5%, respectively. Higher vitamin
D sufficiency rate in our study compared to the
other studies may be explained by the older ages
of children in other studies and seasonal differ-
ences. The study from 2001-2006, the National
Health and Nutrition Examination Survey33,
which showed that the vitamin D deficiency in
children aged 1-5 was lower than those who are
6-11, supports our results.
Variable Correlation* p*
Age -0.80 0.42
Gender 0.05 0.60
Parental atopy presence 0.02 0.84
Sunlight exposure (10 minute >) 0.25 0.01
IgE -0.15 0.14
Eo -0.07 0.48
Duration of disease, months -0.07 0.51
Asthma morbidity (last year)
Number of execerbation -0.27 0.006
Number of emergency service visits -0.14 0.17
Number of hospitalization -0.11 0.27
Asthma Symptoms Scores -0.11 0.27
Asthma severity -0.34 0.001
Asthma Control (GINA) 0.46 0.001
TRACK Scores 0.29 0.004
Table IV. Univariate analysis of associations between
serum Vitamin D levels and clinical variables*.
*Correlation was determined with the Spearman rank corre-
lation coefficient.
number of asthma exacerbations within the last
year was higher in the deficient and insufficient
groups, compared to the sufficient group, while no
difference was observed in the number of hospi-
talizations. Our results are consistent with the re-
sults of Dogruoz et al19. In Childhood Asthma
Management Program (CAMP) study conducted
with 1024 mild-moderate persistent asthmatic
children, low vitamin D levels were retrospective-
ly associated with increased odds of hospitaliza-
tion during the previous year, and prospectively
with severe asthma exacerbations over the follow-
ing four years9. Our study group involved mild to
moderate asthmatic patients and a negative corre-
lation was observed between the numbers of the
previous year’s exacerbation and vitamin D levels,
similar to the CAMP study, while there was no re-
lationship between hospitalization numbers11. The
results of the study that lacked a correlation be-
tween the number of hospitalizations and vitamin
D levels showed similar results as the study of
Allen et al40.
There was no relationship between vitamin D
levels and atopy markers IgE and eosinophil num-
bers in patients with asthma in our study. The re-
sults of current study are similar to the results of
Alyasin et al40, although not with the results of
Brehm et al11 study conducted in Costa Rica.
Currently, the primary aim is to control asth-
ma with asthma guidelines. However, there is no
standard definition of adequate asthma control.
There are a limited number of studies assessing
the relationship between vitamin D and asthma
control in children. In a recent cross-sectional
observational study of 75 Italian children with
asthma, aged 5 to 11 years, Chinellato et al31
documented significant and positive correlations
between serum 25 (OH) D3 levels and improved
spirometric measurements of airway obstruction
and a common measure of asthma control (GINA
and the Childhood Asthma Control Test). Lower
vitamin D levels were associated with poor asth-
ma control and lower lung function. According
to GINA25, significant differences in the level of
asthma control and levels of vitamin D has been
shown in a study conducted with asthmatic chil-
dren aged 2-14 in Turkey. Gupta et al23 conduct-
ed a study that involved steroid resistance and
moderate asthmatics and found a positive rela-
tionship between 25 (OH) D3 levels and ACT,
whereby higher serum 25 (OH) D3 was associat-
ed with better asthma control. Serum vitamin D
was significantly lower in elderly patients with
uncontrolled asthma compared to the ones with
34
controlled disease41. In a placebo controlled
study of Lewis et al42, high-dose vitamin D treat-
ment was initiated for deficiency and sufficiency
in asthmatic patients between the ages of 6-17
for one year. There was no significant difference
in measurements of vitamin D, spirometric val-
ues, and ACT levels in the placebo and treated
groups at the end of the year. However, ACT da-
ta obtained from all visits were pooled, and a
positive correlation was found between serum 25
(OH) D3 levels and ACT scores (Pearson’s r =
0.25, p = 0.05), suggesting an effect of vitamin D
in asthma management. These results showed
that asthma control was better in the sufficient
group compared to the other groups according to
the classification of TRACK and GINA measur-
ing asthma control in children under 4 years old.
A positive correlation was found between vita-
min D levels and asthma control, consistent with
the aforementioned studies. However, Alyasin et
al40 did not identify any significant relationship
between vitamin D levels and asthma control ac-
cording to GINA in children aged 6-18.
However, the present study had some limita-
tions. The sample size was relatively small (n =
204). A larger sample size would have increased
the statistical power to detect associations. We
did not consider the effect of vitamin D con-
sumed by diet in study group.
Conclusions
The rate of vitamin D insufficiency and defi-
ciency were higher in asthmatic children compared
to the controls. We also found a strong inverse re-
lationship between circulating levels of vitamin D
and asthma control parameters. We also showed
that greater exacerbation, increased asthma severi-
ty, and reduced asthma control was associated with
vitamin D deficiency and insufficiency.
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